NEYROS

The research company, carrying out studies and development of new pharmaceutical drug candidate for treatment of neurodegenerative disorders and cerebrovascular ischemia.

NEYROS projects are aimed at creating new pharmaceutical candidates for the treatment of Parkinson's disease, age-related dementia, Alzheimer's disease, as well as anti-ischemic drugs for increasing the duration of the "golden hour" during stroke.

Supported by SKOLKOVO Fund
News
Feedback form
Name *
Phone *
E-mail *
Message *
I agree to the processing of the data provided *

© NEYROS Co., Ltd., 2020